| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9298816 | Medicina Clínica | 2005 | 5 Pages |
Abstract
Gabapentin demonstrated efficacy and safety at doses between 2,700 and 3,600 mg/day as a therapy for the spasticity associated with the upper motor neuron syndrome.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Alessandro Formica, Katia Verger, Josep M. Sol, Claudia Morralla,